Study of Alpha Radioligand Therapy AB001 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

NCT07214961 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer (CRPC)
Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Interventions

DRUG: AB001

Sponsor

ARTBIO Inc.